WaveMan · Form 4
Landry Robert E insider trades
> Search tickers & screens ⌘K
LIVE

Landry Robert E insider trades

Landry Robert E has filed 35 Form 4s with the SEC that we hold, for Regeneron Pharmaceuticals, INC. (REGN) (EVP Finance CFO), Cytokinetics INC (CYTK) (Director) and Zymeworks Inc. (ZYME) (Director). Across all of them we count 0 purchases worth $0 and 120 sales worth $9.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($146.8K). The largest single trade was a sale of 1,226 shares of Regeneron Pharmaceuticals, INC. worth $899.3K, dated 2022-04-11. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-10 and the latest 2026-09-15.

Regeneron Pharmaceuticals, INC. (REGN)

EVP Finance CFO · 28 filings · 118 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-09S, sale reported on Form 454$33.5K2021-08-10
2021-08-09S, sale reported on Form 436$22.4K2021-08-10
2021-08-09S, sale reported on Form 436$22.3K2021-08-10
2021-08-09S, sale reported on Form 458$35.9K2021-08-10
2021-08-09S, sale reported on Form 436$22.2K2021-08-10
2021-08-09S, sale reported on Form 440$24.6K2021-08-10
2021-08-09S, sale reported on Form 466$40.6K2021-08-10
2021-08-09S, sale reported on Form 41$6142021-08-10
2021-08-09S, sale reported on Form 436$22.1K2021-08-10
2021-08-09S, sale reported on Form 41$6112021-08-10
2021-08-10S, sale reported on Form 41$6162021-08-10
2021-08-10S, sale reported on Form 41$6142021-08-10
2021-08-10S, sale reported on Form 450$30.6K2021-08-10
2021-08-10S, sale reported on Form 4433$264.6K2021-08-10
2021-08-10S, sale reported on Form 445$27.9K2021-08-10
2021-08-10S, sale reported on Form 47$4.3K2021-08-10
2021-11-17S, sale reported on Form 4681$439.3K2021-11-18
2021-12-10S, sale reported on Form 47$4.7K2021-12-10
2021-12-10S, sale reported on Form 425$16.5K2021-12-10
2021-12-10S, sale reported on Form 4130$87.0K2021-12-10
2021-12-10S, sale reported on Form 458$38.9K2021-12-10
2021-12-10S, sale reported on Form 414$9.4K2021-12-10
2021-12-10S, sale reported on Form 459$39.7K2021-12-10
2021-12-10S, sale reported on Form 4123$81.4K2021-12-10
2021-12-10S, sale reported on Form 419$12.6K2021-12-10
2021-12-10S, sale reported on Form 415$10.0K2021-12-10
2021-12-10S, sale reported on Form 418$12.0K2021-12-10
2021-12-10S, sale reported on Form 468$45.3K2021-12-10
2021-12-10S, sale reported on Form 4178$118.9K2021-12-10
2021-12-10S, sale reported on Form 42$1.3K2021-12-10
2021-12-10S, sale reported on Form 450$32.9K2021-12-10
2021-12-10S, sale reported on Form 411$7.2K2021-12-10
2021-12-10S, sale reported on Form 44$2.6K2021-12-10
2021-12-13S, sale reported on Form 4116$76.8K2021-12-14
2022-03-16S, sale reported on Form 4300$203.1K2022-03-18
2022-03-17S, sale reported on Form 483$56.9K2022-03-18
2022-03-21S, sale reported on Form 4300$207.9K2022-03-23
2022-03-29S, sale reported on Form 454$36.8K2022-03-30
2022-03-29S, sale reported on Form 4103$70.3K2022-03-30
2022-03-29S, sale reported on Form 4304$207.7K2022-03-30
2022-03-29S, sale reported on Form 4227$155.4K2022-03-30
2022-03-29S, sale reported on Form 4176$120.7K2022-03-30
2022-03-29S, sale reported on Form 4220$151.3K2022-03-30
2022-03-29S, sale reported on Form 4542$373.2K2022-03-30
2022-03-29S, sale reported on Form 4205$141.3K2022-03-30
2022-03-29S, sale reported on Form 437$25.6K2022-03-30
2022-03-29S, sale reported on Form 4226$156.3K2022-03-30
2022-03-29S, sale reported on Form 4147$101.8K2022-03-30
2022-03-29S, sale reported on Form 4103$71.4K2022-03-30
2022-03-29S, sale reported on Form 4147$102.2K2022-03-30
2022-03-29S, sale reported on Form 4192$131.8K2022-03-30
2022-04-01S, sale reported on Form 415$10.5K2022-04-01
2022-04-01S, sale reported on Form 4301$209.3K2022-04-01
2022-04-08S, sale reported on Form 416$11.6K2022-04-11
2022-04-08S, sale reported on Form 430$21.9K2022-04-11
2022-04-08S, sale reported on Form 416$11.7K2022-04-11
2022-04-08S, sale reported on Form 444$32.3K2022-04-11
2022-04-08S, sale reported on Form 443$31.6K2022-04-11
2022-04-08S, sale reported on Form 429$21.4K2022-04-11
2022-04-08S, sale reported on Form 428$20.7K2022-04-11
2022-04-08S, sale reported on Form 432$23.8K2022-04-11
2022-04-08S, sale reported on Form 456$41.7K2022-04-11
2022-04-08S, sale reported on Form 431$23.1K2022-04-11
2022-04-11S, sale reported on Form 474$54.0K2022-04-11
2022-04-11S, sale reported on Form 437$27.1K2022-04-11
2022-04-11S, sale reported on Form 422$16.1K2022-04-11
2022-04-11S, sale reported on Form 41,226$899.3K2022-04-11
2022-04-11S, sale reported on Form 475$55.1K2022-04-11
2022-04-11S, sale reported on Form 4149$109.6K2022-04-11
2022-04-11S, sale reported on Form 4189$139.2K2022-04-11
2022-04-11S, sale reported on Form 422$16.2K2022-04-11
2022-04-11S, sale reported on Form 468$50.2K2022-04-11
2022-10-17S, sale reported on Form 4358$264.7K2022-10-18
2022-11-01S, sale reported on Form 480$60.4K2022-11-02
2022-11-01S, sale reported on Form 419$14.5K2022-11-02
2022-11-01S, sale reported on Form 417$13.0K2022-11-02
2022-11-01S, sale reported on Form 41$7502022-11-02
2022-11-01S, sale reported on Form 440$30.1K2022-11-02
2022-11-01S, sale reported on Form 481$61.2K2022-11-02
2022-11-01S, sale reported on Form 442$31.8K2022-11-02
2022-11-01S, sale reported on Form 470$53.2K2022-11-02
2022-11-01S, sale reported on Form 413$9.9K2022-11-02
2022-11-01S, sale reported on Form 4119$90.6K2022-11-02
2022-12-02S, sale reported on Form 4582$440.3K2022-12-02
2022-12-02S, sale reported on Form 412$9.1K2022-12-02
2022-12-02S, sale reported on Form 416$12.2K2022-12-02
2023-02-03S, sale reported on Form 4739$565.0K2023-02-07
2023-02-06S, sale reported on Form 449$38.7K2023-02-07
2023-02-06S, sale reported on Form 410$7.9K2023-02-07
2023-02-06S, sale reported on Form 43$2.4K2023-02-07
2023-02-06S, sale reported on Form 42$1.6K2023-02-07
2023-02-06S, sale reported on Form 499$78.7K2023-02-07
2023-02-06S, sale reported on Form 459$46.9K2023-02-07
2023-02-06S, sale reported on Form 418$14.3K2023-02-07
2023-02-06S, sale reported on Form 499$78.1K2023-02-07
2023-02-06S, sale reported on Form 458$45.7K2023-02-07
2023-02-06S, sale reported on Form 485$66.8K2023-02-07
2023-02-06S, sale reported on Form 478$61.3K2023-02-07
2023-02-06S, sale reported on Form 428$22.3K2023-02-07
2023-02-06S, sale reported on Form 451$39.9K2023-02-07
Newest 100 of 118

Cytokinetics INC (CYTK)

Director · 5 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-09-11S, sale reported on Form 41,000$74.7K2026-09-11
2026-09-15S, sale reported on Form 41,000$72.1K2026-09-15

Zymeworks Inc. (ZYME)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1585160) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms